Advertisement

Topics

CRISPR Therapeutics raises a $56M IPO, but patent battles, potential stock drops loom

CRISPR Therapeutics raises a $56M IPO, but patent battles, potential stock drops loom by Ben Adams | Oct 19, 2016 3:52am And then there were three: After Editas ($EDIT) and Intellia ($NTLA) went public this year, CRISPR has brought up the rear with its IPO. But the biotech will need to gear up for a […]

Original Article: CRISPR Therapeutics raises a $56M IPO, but patent battles, potential stock drops loom

NEXT ARTICLE

More From BioPortfolio on "CRISPR Therapeutics raises a $56M IPO, but patent battles, potential stock drops loom"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...